Thilo Schroeder, Director at Revolution Medicines, Inc. (RVMD), bought 464,728 shares at $23.18 ($11.0M) on 2022-03-22, disclosed to the SEC on 2022-03-24.
Open-market purchase of $11.0M RVMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.15 | 5,440 | $120K | 1.1% |
| 2 | $22.15 | 5,440 | $120K | 1.1% |
| 3 | $23.18 | 71,186 | $1.7M | 15.0% |
| 4 | $23.18 | 71,186 | $1.7M | 15.0% |
| 5 | $23.69 | 53,501 | $1.3M | 11.5% |
| 6 | $23.69 | 53,501 |
| $1.3M |
| 11.5% |
| 7 | $23.61 | 37,708 | $890K | 8.1% |
| 8 | $23.61 | 37,708 | $890K | 8.1% |
| 9 | $23.99 | 15,410 | $370K | 3.4% |
| 10 | $23.99 | 15,410 | $370K | 3.4% |
| 11 | $24.26 | 49,119 | $1.2M | 10.9% |
| 12 | $24.26 | 49,119 | $1.2M | 10.9% |
| Total | $23.63 avg | 464,728 | $11.0M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-21 | $6.8M | — | Filing → |